E1	Procedure:T1 Name:T2 Temporality:E2
E3	Condition:T3 Name:T4
E5	Procedure:T5 Name:T6 Temporality:E2
E7	Drug:T7 Name:T8
E9	Condition:T9 Name:T10
E11	Condition:T11 Name:T12
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16
E2	Eq-Comparison:T17 Temporal-Period:T18
E4	Condition:T19 Name:T20
E8	Procedure:T22 Name:T64
E10	Procedure:T23 Name:T65
E14	Encounter:T25 
E16	Drug:T27 Acuteness:T28
E18	Drug:T30 Name:T31
E19	Drug:T32 Name:T33
E20	Drug:T34 Name:T29
E21	Drug:T35 Name:T36
E22	Condition:T37 Name:T38
E24	Condition:T40 Temporality:E26 Name:T41
E25	Modifier:T42 
E28	Modifier:T45 Modifies:E24
E30	Observation:T48 Name:T49 Severity:T63
E31	Drug:T50 Name:T51
E32	Procedure:T52 Name:T66
E26	Eq-Comparison:T43 Temporal-Period:T55
E34	Condition:T56 Name:T57 Temporality:E35
E35	Eq-Comparison:T58 Temporal-Period:T59
E29	Assertion:T46 Asserted:E30
E36	Procedure:T60 
E38	Procedure:T47 
E40	Assertion:T62 Asserted:E9
E41	Procedure:T67 Name:T68
E42	Procedure:T69 Name:T70
T1	Procedure 48 79	coronary artery bypass grafting
T2	Procedure-Name 48 79	coronary artery bypass grafting
T3	Condition 739 766	acute myocardial infarction
T4	Condition-Name 739 766	acute myocardial infarction
T5	Procedure 96 118	cardiopulmonary bypass
T6	Procedure-Name 96 118	cardiopulmonary bypass
T7	Drug 346 363	immunosuppression
T8	Drug-Name 346 363	immunosuppression
T9	Condition 510 525	hepatic failure
T10	Condition-Name 510 525	hepatic failure
T11	Condition 230 243	renal failure
T12	Condition-Name 230 243	renal failure
T13	Condition 410 422	polycythemia
T14	Condition-Name 410 422	polycythemia
T15	Condition 424 433	porphyria
T16	Condition-Name 424 433	porphyria
T17	Eq-Comparison 27 34	planned
T18	Eq-Temporal-Period 27 34	planned
T19	Condition 196 226	pathology of the urinary tract
T20	Condition-Name 196 226	pathology of the urinary tract
T22	Procedure 154 164	operations
T23	Procedure 168 181	re-operations
T25	Encounter 144 153	emergency
T27	Drug 279 290	medications
T28	Acuteness 250 257	chronic
T29	Drug-Name 292 296	iron
T30	Drug 298 335	non-steroidal anti-inflammatory drugs
T31	Drug-Name 298 335	non-steroidal anti-inflammatory drugs
T32	Drug 337 343	NSAIDs
T33	Drug-Name 337 343	NSAIDs
T34	Drug 292 296	iron
T35	Drug 368 376	steroids
T36	Drug-Name 368 376	steroids
T37	Condition 437 481	pathological hemoglobin species in anamnesis
T38	Condition-Name 437 481	pathological hemoglobin species in anamnesis
T40	Condition 564 572	diseases
T41	Condition-Name 564 572	diseases
T42	Modifier 539 549	autoimmune
T45	Modifier 553 563	neoplastic
T48	Observation 621 629	bleeding
T49	Observation-Name 621 629	bleeding
T50	Drug 631 651	anti-platelet agents
T51	Drug-Name 631 651	anti-platelet agents
T52	Procedure 773 782	operation
T43	Eq-Comparison 532 538	active
T55	Eq-Temporal-Period 532 538	active
T56	Condition 581 590	infection
T57	Condition-Name 581 590	infection
T58	Eq-Comparison 574 580	active
T59	Eq-Temporal-Period 574 580	active
T46	Assertion 597 608	anticipated
T60	Procedure 491 500	operative
T47	Procedure 387 396	operative
T62	Assertion 501 509	signs of
T63	Severity 609 620	significant
T64	Procedure-Name 154 164	operations
T65	Procedure-Name 168 181	re-operations
T66	Procedure-Name 773 782	operation
T67	Procedure 710 719	operation
T68	Procedure-Name 710 719	operation
T69	Procedure 676 698	blood-derived products
T70	Procedure-Name 676 698	blood-derived products
A1	Eq-Temporal-Period-Value T18 future
A2	Encounter-Type-Value E14 emergency
A5	Eq-Temporal-Period-Value T55 present
A6	Eq-Temporal-Period-Value T59 present
A3	Assertion-Type-Value E29 hypothetical
A9	Assertion-Type-Value E40 possible
A10	Severity-Value T63 severe
A13	Acuteness-Type-Value T28 chronic
R1	Using Arg1:E1 Arg2:E5
R2	Abbrev-Of Arg1:E19 Arg2:E18
R3	Example-Of Arg1:E20 Arg2:E16
R4	Example-Of Arg1:E18 Arg2:E16
R5	Example-Of Arg1:E7 Arg2:E16
R6	Example-Of Arg1:E21 Arg2:E16
R7	Example-Of Arg1:E31 Arg2:E30
R8	Caused-By Arg1:E30 Arg2:E42
R9	Or Arg1:E4 Arg2:E11
R10	Or Arg1:E8 Arg2:E10
R11	Or Arg1:E15 Arg2:E22
R12	Or Arg1:E25 Arg2:E28
R13	After Arg1:E3 Arg2:E32
R14	Before Arg1:E36 Arg2:E9
R15	Before Arg1:E16 Arg2:E38
R16	During Arg1:E42 Arg2:E41
R17	Or Arg1:E13 Arg2:E15
R18	Or Arg1:E20 Arg2:E18
T21	Indication 654 664	suggesting
E6	Indication:T21 Indication-For:E42
